Refining the treatment of advanced nonsmall cell lung cancer. - Wikidata - awgldk - TriplyDB

Refining the treatment of advanced nonsmall cell lung cancer.

Refining the treatment of advanced nonsmall cell lung cancer.

http://www.wikidata.org/entity/Q37645169

about

Refining the treatment of advanced nonsmall cell lung cancer.

http://www.wikidata.org/entity/Q37645169

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 May 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Refining the treatment of advanced nonsmall cell lung cancer.

@en

Refining the treatment of advanced nonsmall cell lung cancer.

@nl

type

label

Refining the treatment of advanced nonsmall cell lung cancer.

@en

Refining the treatment of advanced nonsmall cell lung cancer.

@nl

prefLabel

Refining the treatment of advanced nonsmall cell lung cancer.

@en

Refining the treatment of advanced nonsmall cell lung cancer.

@nl

P1433

Q37645169-51ACCF8F-8F1A-4862-9416-8A34199D6E6C

P1476

Q37645169-D949A183-EED1-4C70-B4C1-CF5AB24AEC92

P2093

Q37645169-03198571-1DFF-40B9-8209-3FB2552602AD

Q37645169-DE1A50DC-D52E-4647-8BE8-8A4269A1D00A

P2860

Q37645169-021E6AF0-1DCE-472F-A6AF-2764CA7845B2

Q37645169-035A6B5E-C8DF-440A-856F-9A0C272D83D1

Q37645169-05431503-D24F-445F-A084-FC0B2B5CBE49

Q37645169-08F63A9E-240A-4057-903D-D76E826BA5AA

Q37645169-094FA6D0-28F5-4BC9-B88F-6B00A788F0F2

Q37645169-0E01212C-5F11-4A88-82C7-9C2026A5151D

Q37645169-128E2B10-93C9-4933-AF57-202FCE7E9D26

Q37645169-1BFD7D9D-CB87-4D43-BD73-7C1E19E21B66

Q37645169-236EF64C-9CF8-4A03-BA0E-5AD08CCB908D

Q37645169-252823E4-9A1A-45BA-97F8-9ACFD0E537FE

P304

Q37645169-5E214A3D-CDAF-41A8-91C1-8E5B338FA2C5

P31

Q37645169-1F0732D1-C8BD-42C5-B111-A1C3D2B2EBDA

P356

Q37645169-5D65752D-238F-401E-BAF7-4C2BA6065FB1

P478

Q37645169-51F4193B-94E4-4016-A8CF-984B4193F1ED

P577

Q37645169-87DC4813-4753-4026-943F-66DA61984466

P698

Q37645169-8FA07D5D-7D23-4506-8597-D32084FF362A

P932

Q37645169-2921398B-FF67-4C5A-B086-5A3A067F2A22

P356

P1433

Lung Cancer: Targets and Therapy

P1476

Refining the treatment of advanced nonsmall cell lung cancer

@en

P2093

Antoinette J Wozniak

http://www.w3.org/2001/XMLSchema#string

Shin Ogita

http://www.w3.org/2001/XMLSchema#string

P2860

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Erlotinib in previously treated non-small-cell lung cancer

Cancer statistics, 2009

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK

P304

9-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/LCTT.S6075

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28210103

http://www.w3.org/2001/XMLSchema#string

P932

5312466

http://www.w3.org/2001/XMLSchema#string